Purina Faces Legal Scrutiny Over Poultry Feed’s Claims in Avian Flu Defense Strategy

Purina Animal Nutrition has positioned itself at the forefront of addressing the avian flu crisis with its poultry feed, which it claims provides a “built-in defense against avian influenza.” This claim is currently under scrutiny from competitors within the industry. The implications for Purina are significant, reminiscent of the 2022 judgment where Vital Pharmaceuticals was penalized $271 million after Monster Energy contested the claims about the content of Bang energy drinks. This exemplifies the increasing scrutiny over comparative advertising within legal and commercial spheres. For more details on Purina’s current legal challenge, the story elaborates on the ongoing dispute here.